We are live on ! Find out more
DRIO icon

DarioHealth

20 hedge funds and large institutions have $4.57M invested in DarioHealth in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

0.01% more ownership

Funds ownership: 0.05%0.06% (+0.01%)

0% more funds holding

Funds holding: 2020 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

14% less capital invested

Capital invested by funds: $5.31M → $4.57M (-$741K)

Holders
20
Holders Change
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

DRIO Hedge Fund Activity: Q2 2019 in Review

20 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2019, worth a combined $4.57M — down 14% from $5.31M a quarter earlier.

Fund positioning in DRIO was balanced in Q2 2019: 3 funds opened new positions, 3 closed out, 5 added to existing stakes and 3 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $604K. The largest seller was BlackRock, exiting entirely with an estimated $28K sold.

  • 20 institutional investors held DarioHealth (DRIO) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $4.57M of DarioHealth stock for Q2 2019, down 14% quarter-over-quarter.
  • 3 funds opened new DarioHealth positions in Q2 2019 and 3 closed out, a net change of 0 holders.
  • The largest DarioHealth buyer in Q2 2019 was Nantahala Capital Management, an estimated $604K added.
  • The largest DarioHealth seller in Q2 2019 was BlackRock, an estimated $28K sold.

Based on aggregated 13F filings for Q2 2019.